blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1034175

EP1034175 - SUBSTITUTED PHENYLOXAZOLIDINONES AND THEIR USE AS ANTIBIOTICS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.12.2003
Database last updated on 07.10.2024
Most recent event   Tooltip19.12.2003Application deemed to be withdrawnpublished on 04.02.2004  [2004/06]
Applicant(s)For all designated states
AstraZeneca UK Limited
15 Stanhope Gate
London W1Y 6LN / GB
[2000/37]
Inventor(s)01 / BETTS, Michael John
Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
02 / SWAIN, Michael Lingard
Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
[2000/37]
Representative(s)Berry, Ian Gordon
AstraZeneca PLC
Global Intellectual Property
Mereside
Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
[N/P]
Former [2000/37]Berry, Ian Gordon
AstraZeneca PLC Global Intellectual Property Mereside Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
Application number, filing date98955759.024.11.1998
[2000/37]
WO1998GB03496
Priority number, dateGB1997002524429.11.1997         Original published format: GB 9725244
[2000/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9928317
Date:10.06.1999
Language:EN
[1999/23]
Type: A1 Application with search report 
No.:EP1034175
Date:13.09.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 10.06.1999 takes the place of the publication of the European patent application.
[2000/37]
Search report(s)International search report - published on:EP10.06.1999
ClassificationIPC:C07D413/14, C07D417/14, A61K31/42, C07D413/10
[2000/37]
CPC:
C07D413/10 (EP,US); A61P31/04 (EP); C07D413/14 (EP,US);
C07D417/14 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/37]
TitleGerman:SUBSTITUIERTE PHENYLOXAZOLIDINONE UND IHRE VERWENDUNG ALS ANITIBIOTIKA[2000/37]
English:SUBSTITUTED PHENYLOXAZOLIDINONES AND THEIR USE AS ANTIBIOTICS[2000/37]
French:PHENYLOXAZOLIDINONES SUBSTITUEES ET LEUR UTILISATION EN TANT QU'ANTIBIOTIQUES[2000/37]
Entry into regional phase29.06.2000National basic fee paid 
29.06.2000Designation fee(s) paid 
29.06.2000Examination fee paid 
Examination procedure27.05.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
29.06.2000Examination requested  [2000/37]
18.03.2003Despatch of a communication from the examining division (Time limit: M04)
29.07.2003Application deemed to be withdrawn, date of legal effect  [2004/06]
03.09.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2004/06]
Fees paidRenewal fee
13.11.2000Renewal fee patent year 03
07.11.2001Renewal fee patent year 04
07.11.2002Renewal fee patent year 05
01.12.2003Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO9731917  (ZENECA LTD [GB], et al) [Y] 1-9 * claim - *;
 [Y]WO9623788  (UPJOHN CO [US], et al) [Y] 1-9 * claim - *;
 [Y]EP0352781  (DU PONT [US]) [Y] 1-9 * claim - *;
 [Y]WO9309103  (UPJOHN CO [US]) [Y] 1-9 * page 8, line 26 - page 9, line 26; claim - *;
 [Y]WO9507271  (UPJOHN CO [US], et al) [Y] 1-9 * claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.